https://orcid.org/0000-0002-9697-9211Dr. Gallie is an Ophthalmologist and President of the International Retinoblastoma Consortium (IRbC). She is a Clinician Scientist in the Retinoblastoma Program at the Hospital for Sick Children and a Professor at the University of Toronto. At University Health Network, she is an Affiliate Scientist in Health Informatics Research (HIR), Princess Margaret Cancer Centre, and the Krembil Research Institute.
She completed her MD at Queen’s University, residency at the University of Toronto, and postgraduate research at Memorial Sloan-Kettering Cancer Center. In 2014, Dr. Gallie was appointed to the Order of Canada in recognition of her research in retinoblastoma, which advanced the understanding of cancer genetics and improved diagnosis and treatment of the disease.
Dr. Gallie developed eCancerCareRB (eCCRB), a database that has facilitated retinoblastoma clinical care at SickKids since 2001. To enhance clinical communication with patients, families, and healthcare teams regardless of geography, IRbC developed DEPICT HEALTH, a full-view-for-life platform in the cloud.
She leads a clinical trial of sustained drug release (Chemoplaque) for intraocular retinoblastoma, reporting minimal toxicity and high response rates for eyes with retinoblastoma that have failed Standard of Care. For the Chemoplaque trial, Dr. Gallie developed novel clinical trial methodologies, including comparison to historic propensity-matched eCCRB controls.